Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Get guidance on which passive funds to buy for retirement, focusing on cost, diversification, and long-term goals.
24,385 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Nvidia has built a fortress around AI-driven growth, but one number could alter the trajectory. This article breaks d...
Barclays just boosted its Oracle price target to $240, highlighting a sharper focus on Oracle's cloud expansion and A...
Fortune Brands Innovations stunned investors with a leadership overhaul after a zero-day CEO exit yielded $18.4 milli...
The U.S. federal debt surpassed $39 trillion for the first time, signaling a turning point for budgeting and markets....
B&G Foods' Q1 2026 earnings set the stage for a cautious yet encouraging year. This guide breaks down the drivers, ri...
A Chicago federal judge has ordered MRED to restore certain listing feeds to Zillow while the zillow, mred face july ...
With the housing market cooling, investors are redirecting capital toward durable infrastructure plays. This report e...
Senator Lummis frames Bitcoin as a hedge against mounting U.S. debt as the CLARITY Act moves closer to a Senate floor...
A Microsoft Copilot AI forecast places Solana on a volatile path to 2026, with a base bull range of $250-$400 and a p...
Dive into a practical look at how Kleiner Perkins evaluates AI startups, drawn from the transcript: mamoon hamid, kle...
Analysts model a five-year horizon for Broadcom, showing a pathway where a $5,000 stake could grow significantly by 2...